The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments
Open accessAbstract
A diagnosis of Parkinson's disease is classically established after the manifestation of motor symptoms such as rigidity, bradykinesia, and tremor. However, a growing body of evidence supports the hypothesis that nonmotor symptoms, especially gastrointestinal dysfunctions, could be considered as early biomarkers since they are ubiquitously found among confirmed patients and occur much earlier than their motor manifestations. According to Braak's hypothesis, the disease is postulated to originate in the intestine and then spread to the brain via the vagus nerve, a phenomenon that would involve other neuronal types than the well-established dopaminergic population. It has therefore been proposed that peripheral nondopaminergic impairments might precede the alteration of dopaminergic neurons in the central nervous system and, ultimately, the emergence of motor symptoms. Considering the growing interest in the gut-brain axis in Parkinson's disease, this review aims at providing a comprehensive picture of the multiple gastrointestinal features of the disease, along with the therapeutic approaches used to reduce their burden. Moreover, we highlight the importance of gastrointestinal symptoms with respect to the patients' responses towards medical treatments and discuss the various possible adverse interactions that can potentially occur, which are still poorly understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonmotor symptoms, including chronic constipation and GI distress, precede motor symptoms in up to 80% of PD patients (O’Sullivan et al., 2008; Poirier et al., 2016; Unger et al., 2016).”
From Microbiome–microglia connections via the gut–brain axis (2019) · cites this paper as Poirier et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 4×
“An early diagnosis of the disease based on the Unified Parkinson’s Disease Rating Scale (UPDRS) has a favorable long-term impact on the quality of life of patients [3].”
InfluentialParkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, К. R., & Schapira, A. H. V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,818
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Clinical Guideline: Management of Gastroparesis
Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.373 · Cited by 1,149
Research works printed but not linked: 10
- 2010, The American Journal of Managed Care, 16, S94
- 2011, American Journal of Managed Care, S308
- 2008, Neuropsychiatric Disease and Treatment, 4, 711
- 2001, BC Medical Journal, 43, 219
- 1995, The American Journal of Gastroenterology, 90, 1741
- 2014, The Cochrane Database of Systematic Reviews, 1
- 2011, Minerva Gastroenterologica e Dietologica, 57, 117
- 1999, Movement Disorders, 14, 1057
- 2003, Neurologia, 18, 2
- 2006, Movement Disorders, 21, S598
Cited by
Sorted by citations
Microbiome–microglia connections via the gut–brain axis
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K. M., Augustijns, P., Basit, A. W., Batchelor, H. K., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 343
Recent developments in understanding the role of the gut microbiota in brain health and disease
Sherwin, E., Dinan, T. G., & Cryan, J. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13416 · Cited by 338
Pellegrini, C., Antonioli, L., Colucci, R., Blandizzi, C., & Fornai, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1856-5 · Cited by 270
Curcumin, Gut Microbiota, and Neuroprotection
Meo, F. D., Margarucci, S., Galderisi, U., Crispi, S., & Peluso, G. (2019) · Nutrients · doi:10.3390/nu11102426 · Cited by 217
Advancement in the modelling and therapeutics of Parkinson’s disease
Nand, S., & Singh, P. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101752 · Cited by 214
Ashique, S., Mohanto, S., Ahmed, M. G., Mishra, N., Garg, A., Chellappan, D. K., Omara, T., Iqbal, S., & Kahwa, I. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34092 · Cited by 205
RetractedThe microbiome-gut-brain axis in acute and chronic brain diseases
Benakis, C., Martin‐Gallausiaux, C., Trezzi, J., Melton, P., Liesz, A., & Wilmes, P. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.009 · Cited by 189
Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10040206 · Cited by 174
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Campos‐Acuña, J., Elgueta, D., & Pacheco, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00239 · Cited by 150
Fu, P., Gao, M., & Yung, K. K. L. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00607 · Cited by 146
Bhattarai, Y., Si, J., Pu, M., Ross, O. A., McLean, P. J., Till, L., Moor, W., Grover, M., Kandimalla, K. K., Margolis, K. G., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1866974 · Cited by 126
Yip, J. L. K., Balasuriya, G. K., Spencer, S. J., & Hill‐Yardin, E. L. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.021 · Cited by 130
Gut microbiota and neurological effects of glyphosate
Rueda‐Ruzafa, L., Cruz, F., Román, P., & Cardona, D. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.006 · Cited by 124
Sun, Y., Sommerville, N. R., Liu, J. Y. H., Ngan, M. P., Poon, D., Ponomarev, E. D., Lu, Z., Kung, J. S. C., & Rudd, J. A. (2020) · The Journal of Physiology · doi:10.1113/jp279919 · Cited by 118
Bhattacharyya, D., Mohite, G. M., Krishnamoorthy, J., Gayen, N., Mehra, S., Navalkar, A., Kotler, S. A., Ratha, B. N., Ghosh, A., Kumar, R., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00733 · Cited by 108
The immunology of Parkinson’s disease
Zhu, B., Yin, D., Zhao, H., & Zhang, L. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00947-3 · Cited by 108
The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists
Lerner, A., Neidhöfer, S., & Matthias, T. (2017) · Microorganisms · doi:10.3390/microorganisms5040066 · Cited by 97
Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease
McGee, D. J., Lu, X.-H., & Disbrow, E. A. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-181327 · Cited by 86
Inadequate Production of H2 by Gut Microbiota and Parkinson Disease
Ostojić, S. M. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.02.006 · Cited by 86
The intestinal immune system and gut barrier function in obesity and ageing
Shemtov, S. J., Emani, R., Bielska, O., Covarrubias, A. J., Verdin, E. M., Andersen, J. K., & Winer, D. A. (2022) · FEBS Journal · doi:10.1111/febs.16558 · Cited by 86
Gastrointestinal dysfunction in Parkinson’s disease
Lubomski, M., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09723-5 · Cited by 84
Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response
Sanz, J. A., & Aidy, S. E. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05224-0 · Cited by 75
Spectrum of Non-Motor Symptoms in Parkinson's Disease
Kumaresan, M., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.13275 · Cited by 73
Clinical implications of gastric complications on levodopa treatment in Parkinson’s disease
Pfeiffer, R. F., Isaacson, S. H., & Pahwa, R. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.001 · Cited by 77
Chandramowlishwaran, P., Vijay, A., Abraham, D., Li, G., Mwangi, S. M., & Srinivasan, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614331 · Cited by 74
Morais, L. H., Hara, D. B., Bicca, M. A., Poli, A., & Takahashi, R. N. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000389 · Cited by 58
Radad, K., Moldzio, R., Krewenka, C., Kranner, B., & Rausch, W. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00036 · Cited by 68
Health-Related Quality of Life for Parkinson’s Disease Patients and Their Caregivers
Lubomski, M., Davis, R. L., & Sue, C. M. (2021) · Journal of Movement Disorders · doi:10.14802/jmd.20079 · Cited by 72
Peterschmitt, M., on behalf of the MOVES-PD Investigators, Saiki, H., Hatano, T., Gasser, T., Isaacson, S., Gaemers, S. J. M., Minini, P., Saubadu, S., Sharma, J., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212714 · Cited by 64
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 61
Ceppa, F., Izzo, L., Sardelli, L., Raimondi, I., Tunesi, M., Albani, D., & Giordano, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00297 · Cited by 58
Emergencies and critical issues in Parkinson’s disease
Simonet, C., TOLOSA, E. S., Cámara, A., & Valldeoriola, F. (2019) · Practical Neurology · doi:10.1136/practneurol-2018-002075 · Cited by 51
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Liu, J., Xu, F., Nie, Z., & Shao, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.570658 · Cited by 52
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 48
Depression in Parkinson's disease: Perspectives from an Australian cohort
Lubomski, M., Davis, R. L., & Sue, C. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.032 · Cited by 43
The sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou‐El‐Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 44
Chen, Y. G., Guo, C., Manousiouthakis, E., Wang, X., Cairns, D. M., Roh, T. T., Du, C., & Kaplan, D. L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000543 · Cited by 44
Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-230206 · Cited by 40
Zhu, Q., Song, J., Chen, J.-Y., Yuan, Z., Liu, L., Xie, L., Liao, Q., Ye, R. D., Chen, X., Yan, Y., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.011 · Cited by 39
Mohamad, K. A., El‐Naga, R. N., & Wahdan, S. A. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115853 · Cited by 38
Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy
Yuan, X.-Y., Chen, Y., & Liu, Z. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i3.225 · Cited by 35
Bi, M., Feng, L., He, J., Liu, C., Wang, Y., Jiang, H., & Liu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101759 · Cited by 32
Levodopa Inhalation Powder: A Review in Parkinson’s Disease
Paik, J. (2020) · Drugs · doi:10.1007/s40265-020-01307-x · Cited by 31
McGuckin, M. B., Hutton, A. R. J., Davis, E. R., Sabri, A. H. B., Ripolin, A., Himawan, A., Naser, Y. A., Ghanma, R., Greer, B., McCarthy, H. O., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00065 · Cited by 30
Palanisamy, B. N., Sarkar, S., Malovic, E., Samidurai, M., Charli, A., Zenitsky, G. D., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106225 · Cited by 29
Kenna, J. E., Bakeberg, M. C., Gorecki, A. M., Tay, C. Y., Winter, S., Mastaglia, F. L., & Anderton, R. S. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13134 · Cited by 27
Yin, S., & Zhu, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1038928 · Cited by 28
Chan, D. G., Ventura, K., Villeneuve, A., Du Bois, P., & Holahan, M. R. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223461 · Cited by 24
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Treatment of Nonmotor Symptoms in Parkinson's Disease
Sauerbier, A., Cova, I., Rosa‐Grilo, M., Taddei, R. N., Mischley, L. K., & Chaudhuri, К. R. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.03.002 · Cited by 24
Adam, H., Gopinath, S. C. B., Arshad, M. K. M., Parmin, N. A., & Hashim, U. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.014 · Cited by 23
Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease
Liu, Y., Wang, W., Song, N., Jiao, L., Jia, F., Du, X., Chen, X., Yan, C., Jiao, J., Jiao, Q., et al. (2022) · Advanced Science · doi:10.1002/advs.202203020 · Cited by 23
Zhu, H., Zhang, H., Hou, B., Xu, B., Ji, L., & Wu, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9110560 · Cited by 22
Does gut brain axis has an impact on Parkinson’s disease (PD)?
Elangovan, A., Dahiya, B., Kirola, L., Iyer, M., Jeeth, P., Maharaj, S., Kumari, N., Lakhanpal, V., Michel, T. M., Rao, K. R. S. S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102171 · Cited by 22
Sheikhpour, E., Mard, S. A., Farbood, Y., Bavarsad, K., & Sarkaki, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121356 · Cited by 21
Antipova, V., Holzmann, C., Hawlitschka, A., Witt, M., & Wree, A. (2021) · Toxins · doi:10.3390/toxins13070505 · Cited by 20
Assessment of Non-Motor Symptoms of Parkinson's Disease and Their Impact on the Quality of Life
Kumar, A., Patil, S., Singh, V. K., Pathak, A., Chaurasia, R. N., Mishra, V. N., & Joshi, D. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_647_21 · Cited by 20
Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson’s disease
Neufeld, P. M., Nettersheim, R., Matschke, V., Vorgerd, M., Stahlke, S., & Theiß, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391304 · Cited by 22
Parkinson’s disease: Are gut microbes involved?
Bhattarai, Y., & Kashyap, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2020 · Cited by 21
Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson’s disease
Boros, F. A., & Vécsei, L. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1999928 · Cited by 16
Liu, Q., Xu, Y., Wan, W., & Ma, Z. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1819-3 · Cited by 16
Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor
Nadeau, J., Smith, T. M., Lamontagne‐Proulx, J., Bourque, M., Al-Sweidi, S., Jayasinghe, D., Ritchie, S. A., Paolo, T. D., & Soulet, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146460 · Cited by 16
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15
Takamatsu, Y., Fujita, M., Ho, G. J., Wada, R., Sugama, S., Takenouchi, T., Waragai, M., Masliah, E., & Hashimoto, M. (2018) · Parkinson s Disease · doi:10.1155/2018/5789424 · Cited by 15
Aging and Nutrition: Theories, Consequences, and Impact of Nutrients
Tittikpina, N. K., Issa, A.-R., Mouhoudine, Y., Dermane, A., Dossim, S., Salou, M., Bakoma, B., Diallo, A., Potchoo, Y., & Diop, Y. M. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00185-6 · Cited by 14
Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
Murtomäki, K., Mertsalmi, T. H., Jaakkola, E., Mäkinen, E., Levo, R., Nojonen, T., Eklund, M. R. E., Nuuttila, S., Lindholm, K., Pekkonen, E., et al. (2022) · Movement Disorders · doi:10.1002/mds.28986 · Cited by 14
Kholy, S. E., Wang, K., El-Seedi, H. R., & Naggar, Y. A. (2021) · Biology · doi:10.3390/biology10100983 · Cited by 12
Characterization of Aspirated Duodenal Fluids from Parkinson’s Disease Patients
de Waal, T., Brouwers, J., Berben, P., Flanagan, T. R., Tack, J. F., Vandenberghe, W., Vanuytsel, T., & Augustijns, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041243 · Cited by 10
Zhang, C., & Arnold, S. L. M. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000964 · Cited by 10
Metta, V., Chung‐Faye, G., Benamer, H. T. S., Kandadai, R. M., Goyal, V., Falup‐Pecurariu, C., Muralidharan, N., Deepak, D., Abdulraheem, M., Borgohain, R., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050711 · Cited by 11
Managing autonomic dysfunction in Parkinson’s disease: a review of emerging drugs
Kulshreshtha, D., Ganguly, J., & Jog, M. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1729120 · Cited by 11
Constipation Management in Parkinson Disease
Cheesman, M., Ho, H., Bishop, K., & Sin, M. (2021) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000611 · Cited by 9
Poirier, A.-A., Côté, M., Jarras, H., Litim, N., Lamontagne‐Proulx, J., Al-Sweidi, S., Morissette, M., Lachhab, A., Pelletier, M., Paolo, T. D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898067 · Cited by 9
Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease
Zou, X., Chen, X., Wen, Y., Jing, X., Luo, M., Xin, F.-Y., Tang, Y., Hu, M., Liu, J., & Xu, F. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1294260 · Cited by 9
Virga, D. M., Capps, J., & Vohra, B. P. S. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2649-x · Cited by 10
Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?
Woerman, A. L., & Tamgüney, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105625 · Cited by 8
Lopresti, A. L., Gupta, H., & Smith, S. J. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2168-y · Cited by 9
Pilipovich, A. A., Ov, V., Makarov, S. A., Shindryaeva, N. N., & Vorob’eva, Y. D. (2022) · Parkinson s Disease · doi:10.1155/2022/1571801 · Cited by 8
Poirier, A.-A., Côté, M., Bourque, M., Jarras, H., Lamontagne‐Proulx, J., Morissette, M., Paolo, T. D., & Soulet, D. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.06.019 · Cited by 10
Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid
Chen, Q.-Z., Shang, J., Jiang, Y., Yang, Y., Zang, C., Ma, J., Dong, Y.-R., Wang, J., Zhou, N., Yang, X., et al. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.115008 · Cited by 7
Esophageal and Gastric Motility Disorders in the Elderly
Shane, M. A. S., & Moshiree, B. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.08.002 · Cited by 7
Hauser, R. A., Ondo, W. G., Zhang, Y., Bowling, A. D., NAVIA, B. A., Pappert, E. J., Isaacson, S., & for the CTH-301 Study Investigators (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-223537 · Cited by 7
Gastrointestinal dysfunction in Parkinson's disease
Timpka, J., & Odin, P. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.07.004 · Cited by 7
Zhao, L., Niu, Q., Yang, K., Zhao, K., Yin, S., & Zhu, F. (2024) · Medicine · doi:10.1097/md.0000000000038937 · Cited by 6
The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9
Khezri, M. R., Esmaeili, A., & Ghasemnejad‐Berenji, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00418 · Cited by 7
Parkinson's disease and patient related outcomes in stroke: A matched cohort study
Perdomo-Lampignano, J. A., Pana, T. A., Sleeman, I. J., Clark, A., Sawanyawisuth, K., Tiamkao, S., & Myint, P. K. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104826 · Cited by 6
Hawlitschka, A., Berg, C., Schmitt, O., Holzmann, C., Wree, A., & Antipova, V. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146877 · Cited by 6
Fogliano, C. A., Rigon, L., Chaudhuri, К. R., Popławska-Domaszewicz, K., Falup‐Pecurariu, C., Murășan, I., Guerra, A., Garon, M., Odin, P., Hattori, N., et al. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2539962 · Cited by 6
Bell, S. M., Evans, J. M., Greif, E. A., Tsai, K. L., Friedenberg, S. G., & Clark, L. A. (2023) · Mammalian Genome · doi:10.1007/s00335-023-09991-2 · Cited by 5
Harnessing the Power of Machine Learning for Parkinson's Disease Detection
Biswas, N., Santra, D., Banerjee, B., & Biswas, S. (2024) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-0786-1.ch008 · Cited by 5
Role of Genes and Treatments for Parkinson’s Disease
Naz, F., & Siddique, Y. H. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010047 · Cited by 5
Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats
Sinen, O., Özkan, A., Ağar, A., & Bülbül, M. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147442 · Cited by 5
Wang, Y., Gao, P., Zhang, X., Lv, B., Xu, Z., & Cheng, H. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.07.112 · Cited by 5
Use of Prebiotics for Addressing Gut Dysbiosis and Achieving Healthy Gut–Brain Axis
Lasrado, L. D., & Rai, A. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_11 · Cited by 6
Murtomäki, K., Joutsa, J., Mertsalmi, T. H., Jaakkola, E., Mäkinen, E., Levo, R., Eklund, M. R. E., Nuuttila, S., Pekkonen, E., Noponen, T., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3097 · Cited by 5
Gastrointestinal Dysfunction in Parkinson’s disease
Alkhazndar, A., Hweidy, K., Rashad, M., & Alboraie, M. A. A. (2022) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2022.112403.1745 · Cited by 5
Lynch‐Godrei, A., Repentigny, Y. D., Yaworski, R., Gagnon, S., Butcher, J., Manoogian, J., Stintzi, A., & Kothary, R. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13773 · Cited by 3
Bazek, M., Sawa, M., Horii, K., Nakamura, N., Iwami, S., Wu, C.-H., Inoue, T., Nin, F., & Abe, C. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00939-y · Cited by 3
Metadata
- Authors
- Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Axe Neurosciences, Centre de Recherche du CHU de Québec (Pavillon CHUL), Quebec City, QC, Canada
- Université Laval (CA)
- Corresponding author
- Soulet, Denis
- Venue
- Parkinson s Disease
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-23
- ISSN
- 2042-0080 (ISSN-L)
- 2090-8083
- PMC
- PMC5168460
- OpenAlex
- W2560353112
- Cited by
- 130
- References
- 217
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 9 · 2023: 18 · 2022: 19 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 9 · 2017: 6
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Parkinson s Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institute of Health Research
- Canadian Foundation for Innovation
- Fonds de la Recherche du Québec-Santé
- Parkinson Québec
- Société Parkinson Canada and La Fondation du CHU de Québec
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- gastrointestinal dysfunction, non-motor symptoms, gut-brain axis, Braak hypothesis, vagus nerve, early biomarkers, gastrointestinal symptoms, treatment side effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
